Singapore's first cell therapy facility broke ground on Tuesday.
Lonza, the leading industry contract manufacturer for globally trusted cellular therapeutics, opened the first cell therapy facility in Asia which is also the first of its kind in Singapore.
Officiating at the groundbreaking of the facility, Singapore's Senior Minister of State for Trade and Industry and Education S Iswaran said that cell therapy holds much promise as a cure for chronic ailments such as stroke, diabetes, and heart disease.
He also said that after identifying cell therapy as a key growth driver, Singapore has built up a foundation for cell therapy research and manufacturing.
He pointed out that Singapore has put in place a strong scientific base in cell therapy research governed by high ethical standards. The people have worked hard to achieve excellence in complex biopharmaceutical manufacturing. Also, Singapore identifies future trends and invests in the training of its people ahead of time to meet companies' demand for skilled workers in these new growth areas.
He also said that by the year 2011, biologics investments in Singapore are projected to employ more than 1,000 people.
Source: Xinhua
|
Comment
Tell A Friend
Print Format
Save Article